Brain-Computer Interfaces and AI: The Future of Accessibility in Nonprofit Services
A technology once confined to science fiction is now restoring communication and independence to people with severe disabilities. Brain-computer interfaces, powered by AI, are reaching clinical reality, and disability-serving nonprofits need to understand what this means for the populations they serve.
In June 2025, a patient diagnosed with ALS spoke through a computer using only his thoughts. Not by eye-tracking, not by slight finger movement, but by neural signals decoded in real time by an AI-powered brain-computer interface. The words came out in his own synthesized voice, with natural pacing and even melody. For the disability community and the organizations that serve it, this moment represents something far beyond a research milestone. It represents the beginning of a technology transition that will reshape what independence looks like for millions of people with severe physical disabilities.
Brain-computer interfaces, known as BCIs, create a direct communication pathway between the brain and external devices. When combined with modern AI, these systems can translate complex neural signals into words, movements, and computer commands with a speed and accuracy that was unimaginable a decade ago. The field is moving from small clinical trials to plans for commercial-scale production, with multiple companies receiving FDA approvals and expanding studies internationally. Approximately 5.4 million Americans live with some form of paralysis, and millions more experience severe communication disabilities from ALS, cerebral palsy, brainstem stroke, or spinal cord injury. For many of them, current assistive technologies impose significant limitations. BCIs, combined with AI, promise to remove those limitations in ways previously impossible.
This article is for nonprofit leaders and staff who serve people with disabilities, whether in direct services, advocacy, policy, or philanthropy. Understanding the BCI landscape, what is clinically real today versus what remains aspirational, what access barriers exist, and what roles nonprofits can play is increasingly important. The organizations that engage with this technology thoughtfully, advocating for their clients' interests and helping shape equitable access, will be better positioned to serve the disability community as this technology matures.
The article also covers the significant ethical, privacy, and policy questions that BCIs raise, many of which touch directly on the values that drive disability-serving nonprofits. Neural data is among the most sensitive personal information that exists, and the regulatory frameworks to protect it are still forming. Nonprofits have both the opportunity and the responsibility to help shape how this technology enters their clients' lives.
What Brain-Computer Interfaces Are and How AI Makes Them Work
A brain-computer interface records electrical signals from neurons in the brain and translates those signals into commands that control external devices, from computers to wheelchairs to robotic arms. The concept has existed in research for decades, but the combination of more sophisticated electrode arrays, improved surgical techniques, and above all, powerful AI has transformed BCIs from research curiosities into practical clinical tools.
AI is not a supplementary feature of modern BCIs. It is the core mechanism that makes them work. Brain signals are extraordinarily complex and noisy. Each person's neural patterns are unique, changing with fatigue, attention, and practice. Traditional signal processing approaches could not handle this complexity. Deep learning systems, including convolutional neural networks, recurrent networks, and transformer architectures borrowed from language AI, can learn to recognize each individual user's neural patterns, filter noise, and decode intent with increasing accuracy over time. When an ALS patient thinks about forming the phoneme that begins a word, an AI model trained on their neural data can recognize that pattern, string it with subsequent phonemes, and produce natural speech output. The AI also continuously improves as it accumulates more data from each user.
The field distinguishes between invasive and non-invasive BCIs. Non-invasive devices, primarily EEG headsets that rest on the scalp, are already commercially available and captured nearly 75 percent of the BCI market in 2025. They require no surgery, pose minimal risk, and are accessible for immediate use. Their limitation is signal quality: scalp EEG captures brain activity through the skull and skin, introducing noise and limiting the specificity of what can be decoded. Non-invasive BCIs can support basic control tasks, such as selecting items from a menu, playing simple games, or controlling smart home devices, but they cannot yet reliably decode natural speech or fine motor intent.
Invasive BCIs, which place electrodes directly on or in brain tissue, provide much higher signal quality. This higher quality enables more complex applications, including speech restoration and precise limb control. The surgical requirement is the significant barrier: these devices are currently only accessible through clinical trials, and they carry the risks associated with any brain surgery. The various companies in this space have developed approaches that range in invasiveness, from Neuralink's approach that involves drilling through the skull to Synchron's endovascular technique that routes electrodes through blood vessels without open brain surgery, to Precision Neuroscience's method that inserts a flexible film through a sub-millimeter incision in the skull.
The Clinical Landscape in 2026: What's Actually Happening
Neuralink's PRIME Study
Moving toward commercial-scale production
By late 2025, Neuralink had implanted its device in 12 people worldwide with severe paralysis. The company expanded its study internationally into the UK, with the first UK patient controlling a computer within hours of surgery. At year's end, Neuralink announced plans for high-volume production in 2026, moving from handcrafted devices toward hundreds or low thousands per year, and compressing surgery time toward under one hour.
- Current participants do not pay for device or surgery
- Long-term aspirational target cost compared to Lasik surgery
- No commercial pricing established yet
Synchron's Stentrode
Endovascular approach without open brain surgery
Synchron's device is inserted through blood vessels, reaching the motor cortex without traditional brain surgery. By late 2025, it had been implanted in 10 volunteers across the US and Australia. A major 2025 development integrated Nvidia AI and the Apple Vision Pro headset, allowing people with severe paralysis to control both digital and physical environments through neural signals.
- 100% of patients met primary safety endpoint over 12 months
- Enables software navigation and communication
- Lower surgical risk than cortical implants
Precision Neuroscience
First FDA 510(k) clearance for a commercial BCI implant
In April 2025, Precision Neuroscience received FDA 510(k) clearance for its Layer 7 Cortical Interface, a flexible film device thinner than one-fifth of a human hair, inserted through a sub-millimeter incision. This is the first commercial clearance for a BCI implant in the United States, representing a landmark regulatory moment even though the device is currently cleared for 30-day implantation.
- 1,024-electrode high-density recording capability
- Tested in 37 patients through clinical partnerships
- Minimally invasive approach reduces surgical risk
Non-Invasive BCIs Available Now
Accessible consumer and research-grade devices
Companies like Emotiv, Muse, and OpenBCI offer EEG-based headsets for consumer and research use. Cognixion produces AR headsets designed specifically for people with complex communication disabilities. These devices require no surgery and are available for purchase today, though their capabilities are more limited than implanted devices.
- Consumer devices range from a few hundred to $2,000
- Supports basic control and neurofeedback applications
- Zero surgical risk, immediate availability
Applications Most Relevant to Disability-Serving Nonprofits
For organizations serving people with severe physical disabilities, understanding which BCI applications are closest to clinical availability helps prioritize where to focus attention. The populations most immediately relevant to this technology include people with ALS, spinal cord injury at the cervical level, locked-in syndrome from brainstem stroke, advanced cerebral palsy with severe motor impairment, and muscular dystrophy.
Communication and Augmentative Speech
Communication restoration is the most advanced BCI application and the one closest to widespread clinical use. The technology works by decoding the neural patterns associated with phonemes, the smallest units of speech, and stringing them into words and sentences. A team at UC Berkeley and UC San Francisco developed a streaming approach in 2025 that achieves near-real-time synthesis, solving the long-standing latency problem that made earlier speech BCIs impractical for natural conversation. For people with ALS or locked-in syndrome who currently rely on eye-tracking devices or letter boards, this represents a fundamentally different quality of communication. The AI component is essential: it must recognize each individual's neural patterns for each phoneme, continuously improve with use, and handle the natural variability of human neural activity.
Nonprofits serving people who use augmentative and alternative communication systems should begin tracking BCI-based AAC developments closely. Organizations that have relationships with speech-language pathologists, assistive technology specialists, and communication support programs will be positioned to help their clients understand when and whether clinical trial participation makes sense, and to advocate for insurance coverage as commercial devices become available.
Mobility and Physical Independence
Thought-controlled wheelchair navigation is an active research area with demonstrated feasibility. A 2025 pilot project identified an approach to convert existing electric wheelchairs into thought-controlled vehicles for approximately $600, with potential to reduce costs by 90 percent compared to dedicated BCI-enabled chairs. Control of smart home devices through neural signals has already been demonstrated by multiple BCI companies with their current trial participants, allowing people with severe paralysis to control lights, temperature, entertainment systems, and door locks through thought alone. For the roughly 305,000 Americans living with traumatic spinal cord injury, and the additional hundreds of thousands with stroke-related or disease-related paralysis, these capabilities represent meaningful gains in daily independence. Organizations that provide independent living services, home modification programs, or assistive technology access should monitor these developments and begin educating their staff about what may become available to clients over the next several years.
Employment and Economic Participation
The employment implications are significant. Only about 15.5 percent of people living with paralysis are currently employed, compared to about 63 percent of people without disabilities. Much of this gap reflects physical access barriers rather than cognitive or motivational factors. By enabling people with severe physical disabilities to control computers, communicate naturally, and interact with digital systems using neural signals, BCIs could substantially expand employment possibilities. Organizations focused on workforce development, vocational rehabilitation, or economic empowerment for people with disabilities should be aware of how BCI technology could change the landscape of what jobs become accessible.
The Access, Cost, and Equity Challenge
The technology is advancing rapidly, but the access challenges are significant and largely unresolved. This is where nonprofit organizations have both the most to contribute and the most to lose if they are not engaged. The communities most likely to benefit from BCI technology are also the communities most likely to be priced out of it if access frameworks are not developed thoughtfully.
No Insurance Coverage Framework Exists
The Government Accountability Office's 2025 BCI policy report explicitly identified Medicaid and private insurance coverage as a major unresolved challenge. There are currently no established reimbursement frameworks for BCI procedures, devices, or follow-up care. Questions remain about who will cover device maintenance, battery replacement, software updates, and eventual device removal or replacement. Without reimbursement frameworks, BCIs will function as luxury technologies accessible only to people who can pay out of pocket. Medicaid-specific BCI coverage advocacy is one of the most important near-term opportunities for disability-serving nonprofits.
Geographic and Specialist Access Barriers
BCI surgery requires specialized neurosurgeons, specialized operating facilities, and specialized follow-up care. Current BCI trial sites are concentrated in major academic medical centers in large cities. For rural communities, the geographic barrier to accessing clinical trials is already substantial, and commercial access will likely follow a similar geographic pattern if no deliberate intervention occurs. Nonprofits serving rural disability communities should be aware of this emerging equity gap and begin considering how telehealth, mobile clinical services, or advocacy might help bridge it.
Design and Research Representation
Historically, BCIs have been designed primarily by researchers and engineers who are not themselves disabled, often without meaningful input from the people who will actually use the technology. This has produced devices and interfaces that reflect the assumptions of their creators rather than the needs of users. The BCI Pioneers Coalition, founded by Ian Burkhart, who regained hand and arm function through BCI technology, is working to ensure that BCI users have a direct voice in shaping research priorities and device design. Disability-serving nonprofits that represent specific populations, ALS communities, spinal cord injury communities, or cerebral palsy communities, have an important role to play in amplifying these user voices and connecting their clients to participatory research opportunities.
Ethical and Privacy Considerations Nonprofits Must Understand
Brain-computer interfaces raise profound ethical questions that go beyond the usual privacy and security concerns associated with digital health technology. Neural data is arguably the most intimate form of personal information that exists. It may reveal emotional states, intentions, cognitive processes, and potentially predict future behaviors in ways that other forms of health data cannot. For organizations that work with vulnerable populations, the stewardship responsibilities around neural data are extraordinary.
Neural Privacy and Data Ownership
A critical and unresolved question is who owns the neural data collected by a BCI device. The device company that manufactured the implant? The hospital or medical team that performed the surgery? The patient? Research in 2025 showed that brain data can reveal not just motor intent but emotional processing, covert speech, and even the content of visual perception. If a user's neural data is collected over months or years and shared with third parties, it could reveal information they never intentionally disclosed. Colorado became the first state to protect neural data as a category requiring specific consent under privacy law in 2024, and several other states are considering similar legislation. At the federal level, the MIND Act introduced in the US Senate in September 2025 would create broader protections. Nonprofits should support this legislation and educate their communities about the importance of neural data rights.
Consent and Vulnerable Populations
The populations most likely to benefit from BCIs, people with advanced ALS, locked-in syndrome, or severe paralysis, often have difficulty with conventional informed consent processes due to their communication limitations. This raises serious questions about the quality of consent obtained before trial enrollment, and about the supports needed to ensure that people genuinely understand what they are agreeing to. Nonprofits that provide advocacy and supported decision-making services have a direct role to play in supporting clients who are considering BCI trial participation. This should not be left solely to the medical system.
Long-Term Device Support and Abandonment Risk
The GAO's 2025 BCI report documented cases in which implanted BCI devices were removed because no post-trial support was available after a clinical trial ended. A person who has adapted their life around a neural implant and then has it removed is in a deeply precarious situation. Questions about what happens when a BCI company goes bankrupt, gets acquired, or simply discontinues a product line are currently unanswered. Nonprofits that advocate for disability rights should push for long-term device support commitments from BCI manufacturers and should advocate for regulatory requirements that ensure continuity of care for trial participants.
Corporate Concentration and Power
A handful of private companies are accumulating both the devices and the neural data. The concentration of brain data, essentially a map of how each user thinks and moves, in private hands raises significant concerns about exploitation, data monetization, and the potential for advertising or behavioral influence based on neural signatures. The disability community, which often includes people with significant economic vulnerability, faces particular risks if BCI companies treat neural data as a commercial asset rather than intimate medical information. Nonprofits should engage in policy advocacy to establish that neural data belongs to the person whose brain generated it and cannot be sold or transferred without explicit, ongoing, revocable consent.
What Disability-Serving Nonprofits Can Do Now and in the Near Term
The BCI field is advancing faster than most people in the disability services community realize, and the window for nonprofits to help shape access policies, advocacy positions, and client preparation is now, before commercial devices arrive and access patterns become entrenched. There is no single playbook for how nonprofits should engage, but the following approaches represent the most practical starting points.
Immediate Actions (Now to 12 Months)
- Subscribe to credible BCI news sources. STAT News, MIT Technology Review, and the FDA's Investigational Device Exemption approval updates provide reliable current information. Develop at least one staff member's baseline literacy on this topic.
- Connect with the Implantable BCI Collaborative Community (iBCI-CC). This is the most important collaborative in the space, bringing together researchers, clinicians, manufacturers, and patient advocacy organizations. It actively seeks input from disability-serving nonprofits and provides a direct channel to influence research priorities and device design.
- Educate staff about current clinical trial opportunities. If your organization serves people with ALS, severe spinal cord injury, or locked-in syndrome, some clients may be eligible for clinical trials. Staff should know how to discuss this honestly and where to find accurate information about current study enrollments.
- Advocate for the MIND Act and neural data privacy legislation. Contact your elected officials in support of federal neural data protections. State-level advocacy for Colorado-style neural privacy laws in your state is also valuable.
- Explore non-invasive BCI tools for current programs. Non-invasive EEG devices are available now. Organizations serving clients who might benefit from computer access through thought-based control can begin exploring pilot applications without waiting for invasive devices to become commercial.
Medium-Term Strategy (1 to 5 Years)
- Begin developing organizational protocols for BCI access. As BCIs move toward commercial availability, organizations serving people with ALS, SCI, and communication disorders should develop frameworks for assessing client eligibility, supporting informed decision-making, and providing follow-up support through the BCI adoption process.
- Advocate for Medicaid BCI coverage. The most consequential access intervention in the near term is establishing reimbursement frameworks. This requires organized advocacy with state Medicaid programs, CMS, and insurance commissioners. Disability nonprofits have the relationships and credibility to lead this advocacy.
- Participate in FDA public comment processes. When FDA issues guidance documents on BCI regulation, or when companies apply for broader commercial clearances, public comment periods provide opportunities for disability-serving organizations to ensure that patient-centered outcomes and equity considerations are part of the regulatory conversation.
- Build partnerships with assistive technology programs. Every state has an Assistive Technology Act program that provides equipment loans, demonstrations, and access to AT devices. These programs will be important partners as BCI devices become available and as organizations need to help clients evaluate whether BCI is appropriate for their situation.
Key Organizations Shaping the BCI Landscape
Several nonprofit and academic organizations are already working to ensure that BCI technology develops in ways that serve the disability community equitably. These organizations represent important partners and resources for nonprofits seeking to engage with this space.
Implantable BCI Collaborative Community
Founded with support from the Dana Foundation and Christopher and Dana Reeve Foundation, the iBCI-CC brings together researchers, clinicians, manufacturers, patient advocacy groups, and individuals with lived experience. Mass General Brigham serves as the administrative convener. This is the most direct channel for disability-serving nonprofits to influence BCI research and policy.
BCI Pioneers Coalition
Founded by Ian Burkhart, who regained hand and arm function through BCI technology, this coalition empowers BCI users to share experiences and advocate for patient-centered research. Burkhart was named to MIT Technology Review's 2025 Innovators Under 35 list for this advocacy work. This organization represents the lived-experience voice in BCI development.
Neurotech Network
Led by Jennifer French, a Paralympian and disability advocate who created the iBCI-CC, Neurotech Network focuses on ensuring that the benefits of neurotechnology reach people with neurological conditions. This organization provides a bridge between the clinical and advocacy communities that disability-serving nonprofits can connect with.
American Association of People with Disabilities
The AAPD runs a monthly Technology Forum with national disability advocacy organizations and tech industry representatives. This forum is tracking BCI developments alongside other assistive technology trends and provides a peer learning resource for disability advocacy organizations that are building their understanding of this space.
Preparing Realistically: What BCIs Cannot Do Yet
The excitement around BCI breakthroughs is sometimes accompanied by overstated claims about what these technologies can do today. Responsible engagement with BCI technology means understanding its current limitations as clearly as its promise. Nonprofits have a particular responsibility to provide accurate information to clients who may encounter sensationalized media coverage and develop unrealistic expectations.
As of early 2026, implanted BCIs remain investigational devices. They are not commercially available for purchase. Accessing them requires meeting specific eligibility criteria for clinical trials, primarily focused on people with ALS, severe spinal cord injury at the cervical level, or brainstem stroke. The clinical trial process involves significant time commitment, travel to specialized centers, close medical monitoring, and uncertainty about long-term outcomes. Current trial participants include a small number of people globally, and the surgical procedures, while advancing in safety, still carry real risks.
Non-invasive BCIs, which are commercially available now, can support a narrower range of applications than their invasive counterparts. They are appropriate for basic computer access, neurofeedback, and research contexts, but they cannot reliably decode natural speech or support the fine motor control that invasive devices can achieve. For many clients, existing assistive technologies, including eye-tracking systems, voice synthesis software, and switch-based computer access, will remain the most appropriate tools for the foreseeable future. The goal of BCI literacy for nonprofits is not to promote the technology indiscriminately but to help clients and families understand the realistic landscape and make informed decisions.
What nonprofits can do right now is build the organizational knowledge, policy positions, and community relationships that will position them to serve their clients well as this technology evolves. The engagement happening today in advocacy networks, policy discussions, and research collaboratives will shape who has access to these transformative technologies in five and ten years. The disability community's voice is essential in that process, and nonprofits are uniquely positioned to ensure it is heard. Organizations that are engaged now, that have built their understanding, developed their policy positions, and established their relationships with the BCI research community, will be able to serve their clients far more effectively when commercial BCIs arrive than those that wait until the technology is already in use.
Conclusion
Brain-computer interfaces powered by AI are transitioning from science fiction to clinical reality faster than most people in the nonprofit sector realize. The technology is not uniformly ready, and important barriers around cost, access, insurance coverage, and privacy remain unresolved. But the fundamental capability, using AI to decode neural signals and translate them into speech, movement, and device control, has been demonstrated in clinical settings with real patients who have severe disabilities. The direction of development is clear, and the pace is accelerating.
For disability-serving nonprofits, the relevant question is not whether this technology will matter but how soon it will matter and who will have access. The history of assistive technology provides cautionary lessons: technologies that promise to transform lives for people with disabilities have often taken decades to reach broad access, and access gaps have frequently been shaped by who advocates effectively for equitable policies. Nonprofits that build their understanding of BCI technology now, that engage with policy processes, that connect with collaborative communities, and that advocate for their clients' interests in the design and regulation of these devices will be far better positioned to serve the disability community as this technology matures.
The person who spoke through a BCI using his own synthesized voice represents what is possible. Ensuring that this possibility is accessible to the full disability community, not just to those with wealth, geographic proximity to major medical centers, or connections to the right research teams, is the work that disability-serving nonprofits are uniquely positioned to do. Engaging with AI accessibility technology through the lens of broader AI for disability services means understanding not just what technology can do, but who it serves and how equitably it does so.
Help Shape the Future of Accessible Technology
Your organization's voice matters in shaping how BCI technology develops and who has access to it. Let's discuss how you can build the knowledge and connections to advocate effectively for your clients.